These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24612204)
1. Association of aromatase (TTTA)n repeat polymorphisms with central precocious puberty in girls. Lee HS; Kim KH; Hwang JS Clin Endocrinol (Oxf); 2014 Sep; 81(3):395-400. PubMed ID: 24612204 [TBL] [Abstract][Full Text] [Related]
2. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475 [TBL] [Abstract][Full Text] [Related]
3. Polymorphic variation in CYP19 and the risk of breast cancer. Baxter SW; Choong DY; Eccles DM; Campbell IG Carcinogenesis; 2001 Feb; 22(2):347-9. PubMed ID: 11181459 [TBL] [Abstract][Full Text] [Related]
4. The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-Analysis. Guo L; Liu Y; Liu L; Shao S; Cao Y; Guo J; Niu H Am J Mens Health; 2021; 15(3):15579883211017033. PubMed ID: 34036824 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Healey CS; Dunning AM; Durocher F; Teare D; Pharoah PD; Luben RN; Easton DF; Ponder BA Carcinogenesis; 2000 Feb; 21(2):189-93. PubMed ID: 10657957 [TBL] [Abstract][Full Text] [Related]
6. KISS1 gene analysis in Korean girls with central precocious puberty: a polymorphism, p.P110T, suggested to exert a protective effect. Ko JM; Lee HS; Hwang JS Endocr J; 2010; 57(8):701-9. PubMed ID: 20631455 [TBL] [Abstract][Full Text] [Related]
7. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Baghaei F; Rosmond R; Westberg L; Hellstrand M; Eriksson E; Holm G; Björntorp P Obes Res; 2003 Apr; 11(4):578-85. PubMed ID: 12690088 [TBL] [Abstract][Full Text] [Related]
8. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193 [TBL] [Abstract][Full Text] [Related]
9. Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report. Altmäe S; Haller K; Peters M; Saare M; Hovatta O; Stavreus-Evers A; Velthut A; Karro H; Metspalu A; Salumets A Reprod Biomed Online; 2009 May; 18(5):651-7. PubMed ID: 19549443 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the association between the CYP19 Tetranucleotide (TTTA)n polymorphism and polycystic ovarian syndrome(PCOS) in Han Chinese women. Hao CF; Zhang N; Qu Q; Wang X; Gu HF; Chen ZJ Neuro Endocrinol Lett; 2010; 31(3):370-4. PubMed ID: 20588246 [TBL] [Abstract][Full Text] [Related]
11. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. Gennari L; Masi L; Merlotti D; Picariello L; Falchetti A; Tanini A; Mavilia C; Del Monte F; Gonnelli S; Lucani B; Gennari C; Brandi ML J Clin Endocrinol Metab; 2004 Jun; 89(6):2803-10. PubMed ID: 15181061 [TBL] [Abstract][Full Text] [Related]
12. The association of aromatase (CYP19) gene variants with sperm concentration and motility. Lazaros L; Xita N; Kaponis A; Hatzi E; Plachouras N; Sofikitis N; Zikopoulos K; Georgiou I Asian J Androl; 2011 Mar; 13(2):292-7. PubMed ID: 21217768 [TBL] [Abstract][Full Text] [Related]
13. Association between gynecomastia and aromatase (CYP19) polymorphisms. Czajka-Oraniec I; Zgliczynski W; Kurylowicz A; Mikula M; Ostrowski J Eur J Endocrinol; 2008 May; 158(5):721-7. PubMed ID: 18426832 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. Masi L; Becherini L; Gennari L; Amedei A; Colli E; Falchetti A; Farci M; Silvestri S; Gonnelli S; Brandi ML J Clin Endocrinol Metab; 2001 May; 86(5):2263-9. PubMed ID: 11344237 [TBL] [Abstract][Full Text] [Related]
15. Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population. Lee SJ; Kim WY; Choi JY; Lee SS; Shin JG J Hum Genet; 2010 Mar; 55(3):189-93. PubMed ID: 20186154 [TBL] [Abstract][Full Text] [Related]
16. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women. Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421 [TBL] [Abstract][Full Text] [Related]
18. Genetic Variations of the KISS1R Gene in Korean Girls with Central Precocious Puberty. Oh YJ; Rhie YJ; Nam HK; Kim HR; Lee KH J Korean Med Sci; 2017 Jan; 32(1):108-114. PubMed ID: 27914139 [TBL] [Abstract][Full Text] [Related]
19. Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population. Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Yamanaka H Anticancer Res; 2003; 23(6D):4941-6. PubMed ID: 14981949 [TBL] [Abstract][Full Text] [Related]
20. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers. Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]